Navigation Links
Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42%
Date:7/18/2014

sales, R&D and SG&A for US GAAP separately disclosed for the presentation of Non GAAP earnings.

Unaudited results for the six months to June 30, 2013 

Non GAAP reconciliation 

6 months to June 30, 2013 US GAAP Adjustments Non GAAP (a) (b) (c) (d) (e) $M $M $M $M $M $M $M Total revenues 2,395.6 - - - - - 2,395.6 Costs and expenses: Cost of product sales 311.7 - - - - (16.3) 295.4 R&D 477.1 (19.9) - - - (8.9) 448.3 SG&A 801.7 (72.0) - - (3.4) (31.7) 694.6 Goodwill impairment charge 7.1 (7.1) - - - - - Gain on sale of product rights (11.0) - - 11.0 - - - Reorganization costs 35.2 - - (35.2) - - - Integration and acquisition costs 21.5 - (21.5) - - - - Depreciation - - - - - 56.9 56.9 Total operating expenses 1,643.3 (99.0) (21.5) (24.2) (3.4) - 1,495.2 Operating income 752.3 99.0 21.5 24.2 3.4 - 900.4 Interest income 1.2 - - - - - 1.2 Interest expense (18.3) - - - - - (18.3) Other expense, net (2.3) - - - - - (2.3) Total other expense, net (19.4) - - - - - (19.4) Income before income taxes and equity in earnings of equity method investees 732.9 99.0 21.5 24.2 3.4 - 881.0 Income taxes (161.9) (21.9) (2.1) (5.8) (1.3) - (193.0) Equity in earnings of equity method investees, net of tax 0.9 - - - - - 0.9 Income from continuing operations 571.9 77.1 19.4 18.4 2.1 - 688.9 Loss from discontinued operations, net of tax (249.0) - - 249.0 - - - Net income 322.9 77.1 19.4 267.4 2.1 - 688.9 Impact of convertible debt, net of tax 15.1 - - - - - 15.1 Numerator for diluted EPS 338.0 77.1 19.4 267.4 2.1 - 704.0 Weighted average number of shares (millions) - diluted 587.5 - - - - - 587.5 Diluted earnings per ADS 172.5c 39.4c 9.9c 136.5c 1.1c - 359.4c

The following items are included in Adjustments:

  1. Amortization and asset impairments: Impairment of IPR&D intangible assets acquired with Movetis ($19.9 million), impairment of goodwill relating to Shire's Regenerative Medicine Business
    '/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
2. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
3. Shire Extends Tender Offer for ViroPharma
4. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
5. MinuteClinic Opens First Clinic Locations in New Hampshire
6. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Shire to Present at the Morgan Stanley Global Healthcare Conference
9. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
10. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
11. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Female Health Company (NASDAQ-CM: FHCO) today announced that ... as Executive Vice President of Global Operations effective September ... Pope will retire from his position as Vice ... Following his retirement, Mr. Pope will continue his affiliation ... to joining The Female Health Company (FHC), Mr. Tayler ...
(Date:9/15/2014)... 2014 Research and Markets has announced the ... report to their offering. Heart defect closure ... closure devices help when closing the ostium/ hole/ deficiency in the ... vessels that occurs in the patients with CHDs. CHD is an ... of birth, which are among the most common types of birth ...
(Date:9/15/2014)... , Sept. 15, 2014   Royal Philips  (NYSE: ... growing range of advanced women,s healthcare imaging solutions will ... for Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress, ... . "We,re continually investing in ... and outcomes," said Vitor Rocha , CEO and ...
Breaking Medicine Technology:The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 3Global Heart Defect Closure Devices Market 2014-2018: Key Vendors are Boston Scientific, St. Jude Medical, W.L. Gore and Associates 2Global Heart Defect Closure Devices Market 2014-2018: Key Vendors are Boston Scientific, St. Jude Medical, W.L. Gore and Associates 3Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 2Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 3
(Date:9/15/2014)... York (PRWEB) September 15, 2014 Transvaginal ... Inc. continue to move forward in the federal multidistrict ... of West Virginia, Bernstein Liebhard LLP reports. According to ... Final Order on September 10th that provides for the ... notes that none of the affected plaintiffs has objected ...
(Date:9/15/2014)... MONDAY, Sept. 15, 2014 (HealthDay News) -- U.S. heart ... an electrocardiogram (ECG) when evaluating young people for underlying ... The American Heart Association and the American College ... more detailed personal and family medical history along with ... genetic or congenital (existing from birth) risks for sudden ...
(Date:9/15/2014)... the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer ... affecting both the front and the crown of their ... risk of developing aggressive prostate cancer (usually indicates a ... non-aggressive prostate cancer) later in life, compared to men ... other patterns of baldness and prostate cancer risk. The ...
(Date:9/15/2014)... 2014 - An estimated 8% of Americans will suffer ... during their lifetime. Brought on by an overwhelming or ... altered chemistry and physiology of the brain. Understanding how ... altered by PTSD is essential to developing effective interventions. ... at The University of Texas at Dallas published online ...
(Date:9/15/2014)... FL (PRWEB) September 15, 2014 The ... away from putting low-level offenders in jail and prison ... Group sees this shift as a positive change. , ... prescription drug and heroin abuse. According to an ... parties are calling for a shift away from using ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2Health News:EEG study findings reveal how fear is processed in the brain 2Health News:White House Shifts Policy on Drugs 2
... body of basic animal research and studies of abused ... for the hypothesis that individuals with particular genotypes are ... with the abuse of alcohol and other substances. ... assume that these genotypes identify people who are predestined ...
... Board of Directors Audit Committee Members and Complies with ... BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today ... J. Wilson as vice president of finance and principal ... team. She brings over twenty years of finance ...
... of Suntan Lotions, Reducing Risk of Deadly Skin Cancer ... & Prevention MonthNEW YORK, April 29 The ... people avoid overexposure to harmful ultraviolet radiation from the ... all across America reduce the risk of skin cancer ...
... 23-month-old child in Texas; CDC warns more deaths are ... 23-month-old child in Texas has become the first U.S. ... officials said Wednesday morning. , Dr. Richard Besser, acting ... Prevention, confirmed the death. No other details on the ...
... Dr. Gordon Norman presents overview of US healthcare ... Federation of Health Plans Meeting in Boston- Noted ... value for its healthcare investment- Emphasized greater coordination ... resolve today,s healthcare challenges MARIETTA, Ga., April 29 ...
... & Mentally IllNEW YORK, April 29 May marks ... it, philanthropic-minded New Yorkers will raise money for Weston ... and physically disabled. As federal and state funding ... the current economy, supporters will raise funds amidst live ...
Cached Medicine News:Health News:Genetic risk for anxiety does not have to be destiny 2Health News:PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer 2Health News:Easy-to-Use Wristband Tells You When to Apply Sunscreen - and When to Hit the Shade 2Health News:Easy-to-Use Wristband Tells You When to Apply Sunscreen - and When to Hit the Shade 3Health News:U.S. Reports First Swine Flu Death 2Health News:U.S. Reports First Swine Flu Death 3Health News:Alere's Dr. Gordon Norman Highlights Challenges and Promising Solutions to U.S. Healthcare System to International Health Insurance Executives 2Health News:Alere's Dr. Gordon Norman Highlights Challenges and Promising Solutions to U.S. Healthcare System to International Health Insurance Executives 3Health News:Weston United Celebrates Mental Health Month on May 19th 2
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: